arBtrage CAPITALIZING MARKETS checking… Sign in

VistaGen Therapeutics, Inc.

VTGN Health Care Biotechnology: Pharmaceutical Preparations
$0.54
▼ -5.5% Today
as of Jun 7, 06:45 ET
Last 30 days -10.00% Apr 28 → Jun 05
$0.53 $0.57 $0.61 $0.64 $0.68 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$0.57
High
$0.58
Low
$0.54
Volume
$489,530
Avg Vol
$1M
Mkt Cap
$23M
P/E (TTM)
Beta
52w High
$5.14
52w Low
$0.43
Div Yield
Shares Out

Overview

52-week range
$0.43
$5.14
2% of range
Avg surprise (last 1)
+17.3%
Avg reaction (last 1)
+0.8%
100% positive
Latest IV / EM
697%
EM ±96.5% · $1 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.94$-0.76$-0.58$-0.40$-0.22 Actual $-0.94Actual $-0.66Actual $-0.22Actual $-0.35Actual $-0.42Actual $-0.46Actual $-0.43Est $-0.52Actual $-0.54Actual $-0.45 JunSepDecJunSepDecMar/2025SepDec
Revenue vs Net Income Revenue Net income
$-19M$-17M$-15M$-13M$-11M Jun 24Sep 24Dec 24Jun 25Sep 25Dec 25

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Dec 31, 2025Dec 2025 $-0.45 financials
Tue Sep 30, 2025Sep 2025 $-0.54 financials
Tue Jun 17, 2025Mar/2025 $-0.43 $-0.52 +17.3% +0.8% earnings
Tue Dec 31, 2024Dec 2024 $-0.46 financials
Mon Sep 30, 2024Sep 2024 $-0.42 financials
Sun Jun 30, 2024Jun 2024 $-0.35 financials
Sun Dec 31, 2023Dec 2023 $-0.22 financials
Sat Sep 30, 2023Sep 2023 $-0.66 financials
Fri Jun 30, 2023Jun 2023 $-0.94 financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Jun 16, 2026Mar/2026OTHER -$0.42-$0.43 +2.3%

Financials

Income statement (quarterly)

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
Cost of revenue
Gross profit
Operating income$-20M$-20M$-16M$-15M$-14M$-12M
Net income$-19M$-19M$-15M$-14M$-13M$-11M
EPS (diluted)$-0.45$-0.54$-0.47$-0.46$-0.42$-0.35

Balance sheet (quarterly)

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Cash & equivalents$47M$63M$49M$67M$75M$84M$103M$119M
Inventory
Total current assets$63M$79M$67M$82M$90M$100M$111M$121M
Total assets$65M$81M$69M$84M$92M$102M$114M$124M
Long-term debt
Total liabilities$14M$15M$12M$14M$11M$10M$9M$9M
Total equity$51M$66M$57M$70M$81M$93M$105M$114M

Implied volatility — last 90 days

223%342%460%578%696% Jun 06 — IV 224% · EM ±39.7%Jun 07 — IV 697% · EM ±96.5%

Sector peers